SGLT-2 Inhibitors May Cut Dementia Risk in Patients With Diabetes
Findings show greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.